Open An Account
Best Online Share Trading and Investing Broker in India | mastertrust

Abbott India Ltd.

BSE : 100488 NSE : ABBOTINDIA ISIN : INE358A01014 Industry : Pharmaceuticals & Drugs
21,893.80
B S Sip
Change: -7.65 (-0.03 %)
As on 29-May-2023 12:00 AM
Advance Chart
Prev.Close 21,901.45
Open 21,970.00
Day's High 21,988.00
Day's Low 21,747.00
Mkt.Cap ( Cr.) 46,522.14
Face Value 10.00
PE Ratio 48.96
PB Ratio 13.55

52 Week High Low

Low: 17,325.00
High: 23,140.00
LTP:21,893.80

Lifetime High Low

Low: 1,251.00
High: 23,934.45
LTP:21,893.80

Abbott India Ltd.

BSE : 100488 NSE : ABBOTINDIA ISIN : INE358A01014 Industry : Pharmaceuticals & Drugs
21,875.35
B S Sip
Change: -17.05 (-0.08 %)
As on 29-May-2023 12:00 AM
Advance Chart
Prev.Close 21,892.40
Open 21,889.65
Day High 21,971.45
Day Low 21,736.10
Mkt.Cap ( Cr. ) 46,482.93
Face Value 10.00
P/E Ratio 48.96
PB Ratio 13.55

52 Week High Low

Low:17,349.05
High:23,142.55
LTP:21,875.35

Lifetime High Low

Low:1,300.05
High:23,902.30
LTP:21,875.35
Advance Chart

P/E Ratio

52 W L(14.96)
52 W H(40.26)

P/E Ratio

52 W L(14.96)
52 W H(40.26)
Had I Invested a sum of 1,00,000 on the same day 5 years ago,the money would have become 327452.48 ( a of 26.77 p.a.)

Key Levels and Moving Averages

Take a quick peak at the technical support and resistance levels of the stock price along with various moving average numbers automatically calculated for you

Key Levels

Support Level 1 21,740.42
Support Level 2 21,579.38
Resistance Level 1 22,002.07
Resistance Level 2 22,102.68

Moving Average

20 Days 21,750.20
50 Days 21,777.14
100 Days 21,450.48
200 Days 20,379.57

Peer Companies

Compare the performance of a stock with the other stocks from the same sector

Sotac Pharmaceuticals Ltd. 139.80 Change: 14.80 (11.84%)
PE : 53.66
1Y Return: 0.00%

B S
Bafna Pharmaceuticals Ltd. 97.65 Change: 4.65 (5.00%)
PE : 20.54
1Y Return: -18.49%

B S
Walpar Nutritions Ltd. 86.35 Change: 4.10 (4.98%)
PE : 68.72
1Y Return: 118.33%

B S
Ind-Swift Ltd. 8.80 Change: 0.40 (4.76%)
PE : 0.00
1Y Return: -6.38%

B S
View More

Key Ratios

A quick glance at the key aspects of the company's financial picture such as liquidity, profitability and earnings strength

FY 2022FY 2021FY 2020FY 2019FY 2018
EBDITA Margin (%)23.1422.4221.2819.5219.40
PBT Margin (%)21.4520.7119.6119.0018.79
PAT Margin (%)15.8715.4514.4912.2412.13
ROCE (%)40.5337.5236.5437.8840.61
ROE (%)29.9527.8927.0924.6626.35

Profit & Loss

Stay on top of the company’s Quarterly/Half Yearly/Yearly P&L statement to take an in-depth look at a company’s financial performance

FY 2022FY 2021FY 2020FY 2019FY 2018
Total Income ( Cr.)4,996.674,393.494,207.803,792.583,416.59
Gross Profit ( Cr.)1,145.83984.08862.31715.78637.67
Profit Before Tax ( Cr.)1,079.73925.95802.70698.85621.48
Tax ( Cr.)281.03235.26209.77248.52220.26
Profit After Tax ( Cr.)798.70690.69592.93450.33401.22

Shareholding Pattern & Management

NAME DESIGNATION
Munir Shaikh Chairman
Vivek V Kamath Managing Director
Anisha Motwani Non Executive Independent Director
Sudarshan Jain Non Executive Independent Director
Shalini Kamath Non Executive Independent Director
Ambati Venu Non Executive Director
Kaiyomarz Marfatia Non Executive Director
Rajiv Sonalker Whole Time Director
Sabina Ewing Non Executive Director
Krupa Anandpara Company Secretary

Corporate Action

Stay abreast of the latest bonus, dividend and other corporate action news of the company to take informed investment decisions

No Data Available

MF Holding

Take a peek into the mutual funds, which hold the stock in their portfolio as of the last reported quarter

Scheme Name AUM% Value(Rs. Cr.) Holding Date
Axis Midcap Fund - Regular Plan - Growth Know More 1.72 335.71 30-Apr-2023
PGIM India Midcap Opportunities Fund - Regular Plan - Growth Know More 2.77 223.24 30-Apr-2023
SBI Magnum Global Fund - Regular Plan - IDCW Know More 4.03 222.97 30-Apr-2023
Canara Robeco Emerging Equities - Regular Plan - Growth Know More 1.29 206.37 30-Apr-2023
Nippon India Pharma Fund - Growth Know More 4.27 192.63 30-Apr-2023
View More

News

Abbott India reports Profit after tax of Rs 2314.20 Mln, in the March 2023 quarter
Type: CORPORATE RESULT
Date: 19-May-2023 04:03 PM
--
Abbott India reports Profit after tax of Rs 2468.30 Mln, in the December 2022 quarter
Type: CORPORATE RESULT
Date: 10-Feb-2023 02:01 PM
--
Abbott India reports Profit after tax of Rs 2655.20 Mln, in the September 2022 quarter
Type: CORPORATE RESULT
Date: 14-Nov-2022 01:17 PM
--
Abbott India shines on BSE
Type: MOVERS TODAY
Date: 19-May-2022 10:04 AM
The company has reported 39% rise in Q4 net profit
Abbott India rises on reporting 39% rise in Q4 net profit
Type: MOVERS TODAY
Date: 18-May-2022 02:17 PM
For the year ended March 31, 2022, the company has reported a rise of 15.64% in its net profit at Rs 798.70 crore
Abbott India reports 39% rise in Q4 net profit
Type: NEWS
Date: 18-May-2022 12:08 PM
For the year ended March 31, 2022, the company has reported a rise of 15.64% in its net profit at Rs 798.70 crore
View More